NCT03356470 2026-01-28
Pilot Study of Biomarkers of Response to Immune Checkpoint Blockade in Metastatic Melanoma
University of Wisconsin, Madison
Completed
Clinical Trials
24 trialsNCT04067115 2025-12-17
U01CA236220
Sarcoma Alliance for Research through Collaboration
Phase 1/2 Completed
NCT01244737 2024-07-11
FLT-PET Imaging of Brain Tumors in Children
Boston Children's Hospital
Phase 2 Completed
NCT00880074 2023-06-26
FLT-PET in Predicting Response to Chemotherapy in Patients With Advanced Malignancies
M.D. Anderson Cancer Center
Phase 1 Completed
NCT01399658 2023-03-14
AMIGO
Dana-Farber Cancer Institute
Phase 2 Completed
NCT00813566 2022-04-27
Multi-Tracer PET Assessment of Primary Brain Tumors
University of Utah
Phase 1 Completed
NCT02055586 2020-09-18
FLT-PET/MRI for Early Response Monitoring to Novel Cancer Therapeutic Agents
Case Comprehensive Cancer Center
Completed
NCT02167204 2020-01-13
18F-FLT PET/CT in Measuring Cell Proliferation in Patients With Brain Tumors
University of Washington
Phase NA Completed
NCT02146222 2019-11-18
VEGFR/PDGFR Dual Kinase Inhibitor X-82 and Docetaxel in Treating Patients With Solid Tumors
University of Wisconsin, Madison
Phase 1 Completed
NCT01480050 2019-05-22
Mibefradil Dihydrochloride and Temozolomide in Treating Patients With Recurrent Glioma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 1 Completed
NCT01717391 2019-03-26
[F-18] Fluorothymidine PET/CT Imaging for Pelvic Cancers
University of Iowa
Phase 2 Completed
NCT00276770 2019-02-27
Positron Emission Tomography Using Fluorothymidine F 18 in Finding Recurrent Disease in Patients With Gliomas
University of Washington
Phase NA Completed
NCT00575393 2018-10-09
Gold Sodium Thiomalate in Treating Patients With Advanced Non-Small Cell Lung Cancer
Mayo Clinic
Phase 1 Completed
NCT01928186 2018-05-15
FLT PET in Measuring Treatment Response in Patients With Newly Diagnosed Estrogen Receptor-Positive, HER2-Negative Stage I-III Breast Cancer
University of Washington
Phase NA Completed
NCT01825902 2017-11-20
18F-FLT Positron Emission Tomography and Diffusion-Weighted Magnetic Resonance Imaging in Planning Surgery and Radiation Therapy and Measuring Response in Patients With Newly Diagnosed Ewing Sarcoma
Mayo Clinic
Phase EARLY_PHASE1 Completed
NCT00757549 2017-10-31
3'-Deoxy-3'-[18F] Fluorothymidine and Fludeoxyglucose F 18 PET Scans in Evaluating Response to Cetuximab, Cisplatin, and Radiation Therapy in Patients With Advanced Cancer of the Oropharynx, Larynx, or Hypopharynx
Mayo Clinic
Phase EARLY_PHASE1 Completed
NCT00499135 2017-10-10
Sunitinib Malate in Treating Patients With Unresectable or Metastatic Kidney Cancer or Other Advanced Solid Tumors
National Cancer Institute (NCI)
Phase 1 Completed
NCT00062374 2017-07-06
Irinotecan and Cisplatin in Treating Patients Who Are Undergoing Surgery For Locally Advanced Cancer of the Stomach or Gastroesophageal Junction
National Cancer Institute (NCI)
Phase 2 Completed
NCT00453362 2017-03-31
A Study of Changes in FDG- and FLT-PET Imaging in Patients With Non-Small Cell Lung Cancer Following Treatment With Erlotinib
Genentech, Inc.
Phase 1/2 Completed
NCT00963807 2017-03-17
A Comparison of FLT to FDG PET/CT in the Early Assessment of Chemotherapy Response in Stage IB-IIIA Resectable NSCLC
National Cancer Institute (NCI)
Phase 2 Completed
NCT00572728 2016-12-30
Phase II Study of Fluorine-18 3'-Deoxy-3'-Fluorothymidine (F-18-FLT) in Invasive Breast Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT01480583 2016-07-13
GRABM-B
Angiochem Inc
Phase 2 Completed
NCT00534274 2014-12-16
Positron Emission Tomography Using 3'-Deoxy-3'-(18F) Fluorothymidine in Treating Women With Locally Advanced Cancer in One Breast Who Are Receiving Chemotherapy
UNICANCER
Phase NA Completed
NCT00553748 2008-07-03
Phase I, Open Label, Single Center Safety Study of [F-18]FLT
Siemens Molecular Imaging
Phase 1 Completed